Kathrine Elisabeth Andreassen

Kathrine Elisabeth Andreassen

Chairman at SENSIDOSE AB
60 year
Health Technology
Consumer Services
Electronic Technology

Profile

Kathrine Elisabeth Andreassen currently works at Sensidose AB, as Chairman, Soleglad Invest AS, as Chairman, Questback Group AS, as Director from 2021, and Navamedic AS, as Co-Owner.
Ms. Andreassen also formerly worked at Weifa ASA, as Chief Executive Officer from 2015 to 2018, Navamedic ASA, as Chief Executive Officer from 2019 to 2026, Kemetyl UK Ltd., as Director-Group Marketing & Communications, Observe Medical ASA, as Director from 2019 to 2025, Weifa AS, as Director & Vice President-Consumer Health, and Vistin Pharma ASA, as Independent Director from 2015 to 2017.
Ms. Andreassen received her graduate degree from the University of Wisconsin and undergraduate degree from Oslo Business School.

Kathrine Elisabeth Andreassen active positions

CompaniesPositionStart
QUESTBACK GROUP Director/Board Member 01/08/2021
SENSIDOSE AB Chairman -
Corporate Officer/Principal -
Chairman -

Former positions of Kathrine Elisabeth Andreassen

CompaniesPositionEnd
NAVAMEDIC ASA Chief Executive Officer 16/06/2026
OBSERVE MEDICAL ASA Director/Board Member 05/02/2025
WEIFA ASA Chief Executive Officer 01/04/2018
VISTIN PHARMA ASA Director/Board Member 01/06/2017
Director/Board Member -
See the detail of Kathrine Elisabeth Andreassen's experience

Education of Kathrine Elisabeth Andreassen

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

63

1st degree connections

12

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies12

Utilities

Consumer Services

Health Technology

Distribution Services

Health Technology

Electronic Technology

Consumer Services

Health Technology

Commercial Services

Health Technology

Electronic Technology

Technology Services

  1. Stock Market
  2. Insiders
  3. Kathrine Elisabeth Andreassen